Carers booklets
Is there anything else I can offer to the carers of my patients to provide additional support?
Two carer booklets have been developed to accompany the patient booklets, which have lots of helpful information for the family and friends of your patients, whether they are living with treatment-resistant depression (TRD), or experiencing a psychiatric emergency due to major depressive disorder (MDD-PE).
.png?width=265&height=218&format=webp&quality=60)
.png?width=265&height=218&format=webp&quality=60)
NEW
Learn more about what makes SPRAVATO® a breakthrough therapy*[1][2]
Connect with peers who have SPRAVATO® prescribing experience.
Access live and recorded meetings
* Following the approval of the SSRI fluoxetine in 1987, approved treatments have continued to primarily target the monoaminergic system.[3][4] In contrast, SPRAVATO® is an antagonist of the NMDA glutamate receptor.[5]
Abbreviations
MDD-PE, psychiatric emergency due to major depressive disorder; NMDA, N-methyl-D-aspartate; SSRI, selective serotonin reuptake inhibitor; TRD, treatment-resistant depression.
[Insert local AE reporting text as required]
[Insert link to PI]
[Request information from the Janssen Medical Information team]
[Contact your Janssen Account Manager or Medical Scientific Liaison Manager]
